Cargando…

Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance

The increasing incidence and prevalence of multi-drug resistance (MDR) among contemporary Gram-negative bacteria represents a significant threat to human health. Since their discovery, β-lactam antibiotics have been a major component of the armamentarium against these serious pathogens. Unfortunatel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watkins, Richard R., Papp-Wallace, Krisztina M., Drawz, Sarah M., Bonomo, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871716/ https://www.ncbi.nlm.nih.gov/pubmed/24399995 http://dx.doi.org/10.3389/fmicb.2013.00392

Ejemplares similares

Editorial: Structural and Biochemical Aspects of the Interaction of β-Lactamases With State-of-the-Art Inhibitors
por: Papp-Wallace, Krisztina M., et al.
Publicado: (2022)

Durlobactam, a Broad-Spectrum Serine β-lactamase Inhibitor, Restores Sulbactam Activity Against Acinetobacter Species
por: Papp-Wallace, Krisztina M, et al.
Publicado: (2023)

Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent
por: Barnes, Melissa D., et al.
Publicado: (2019)

The Novel β-Lactamase Inhibitor, ETX-2514, in Combination with Sulbactam Effectively Inhibits Acinetobacter baumannii
por: Barnes, Melissa D, et al.
Publicado: (2017)

AAI101, a Novel β-Lactamase Inhibitor: Microbiological and Enzymatic Profiling
por: Papp-Wallace, Krisztina M, et al.
Publicado: (2017)

The Effectiveness of Imipenem–Relebactam against Ceftazidime-Avibactam Resistant Variants of the KPC-2 β-Lactamase
por: Papp-Wallace, Krisztina M., et al.
Publicado: (2023)

Inhibition of Klebsiella β-Lactamases (SHV-1 and KPC-2) by Avibactam: A Structural Study
por: Krishnan, Nikhil P., et al.
Publicado: (2015)

The Scourge
Publicado: (1876)

Molecular Investigations of PenA-mediated β-lactam Resistance in Burkholderia pseudomallei
por: Rholl, Drew A., et al.
Publicado: (2011)

698. Nacubactam Inhibits Class A β-lactamases
por: Barnes, Melissa D, et al.
Publicado: (2018)

Exploring Additional Dimensions of Complexity in Inhibitor Design for Serine β-Lactamases: Mechanistic and Intra- and Inter-molecular Chemistry Approaches
por: van den Akker, Focco, et al.
Publicado: (2018)

1642. A Novel β-lactamase Inhibitor (Durlobactam, DUR) and β-Lactams Enhance Susceptibility Against Multidrug-Resistant (MDR) Mycobacterium abscessus (Mab)
por: Dousa, Khalid M, et al.
Publicado: (2020)

Insights Into the Inhibition of MOX-1 β-Lactamase by S02030, a Boronic Acid Transition State Inhibitor
por: Ishikawa, Tatsuya, et al.
Publicado: (2021)

The Scourge of India
Publicado: (1895)

The scourge of cartelization
por: Grover, Harpreet Singh
Publicado: (2020)

The Role of Hydrophobic Nodes in the Dynamics of Class A β-Lactamases
por: Olehnovics, Edgar, et al.
Publicado: (2021)

Penicillanic Acid Sulfones Inactivate the Extended-Spectrum β-Lactamase CTX-M-15 through Formation of a Serine-Lysine Cross-Link: an Alternative Mechanism of β-Lactamase Inhibition
por: Hinchliffe, Philip, et al.
Publicado: (2022)

Extended-Spectrum β-Lactamases in Human Isolates of Multidrug-Resistant Non-typhoidal Salmonella enterica
por: Sedrakyan, Anahit M., et al.
Publicado: (2020)

The Class A β-Lactamase Produced by Burkholderia Species Compromises the Potency of Tebipenem against a Panel of Isolates from the United States
por: Becka, Scott A., et al.
Publicado: (2022)

Multidrug-Resistant Escherichia albertii: Co-occurrence of β-Lactamase and MCR-1 Encoding Genes
por: Li, Qun, et al.
Publicado: (2018)

The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic
por: Chowdhary, Anuradha, et al.
Publicado: (2020)

On the Seven Scourges of India
Publicado: (1924)

The Scourge of Predatory Journals
por: Kumar, Ranesh, et al.
Publicado: (2020)

The scourge of vaccine falsification
por: Saliou, Pierre, et al.
Publicado: (2022)

Evaluating the Efficacies of Carbapenem/β-Lactamase Inhibitors Against Carbapenem-Resistant Gram-Negative Bacteria in vitro and in vivo
por: El Hafi, Bassam, et al.
Publicado: (2019)

Antibiofilm Activity of β-Lactam/β-Lactamase Inhibitor Combination against Multidrug-Resistant Salmonella Typhimurium
por: Laure, Nana Nguefang, et al.
Publicado: (2022)

Congenital syphilis: The continuing scourge
por: Agrawal, Prachi G., et al.
Publicado: (2014)

Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam
por: Shapiro, Adam B., et al.
Publicado: (2021)

2385. Ceftazidime–Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa
por: Papp-Wallace, Krisztina M, et al.
Publicado: (2018)

1437. Biochemical characterization of L1 and L2 β-lactamases from clinical isolates of Stenotrophomonas maltophilia
por: Mojica, Maria F, et al.
Publicado: (2020)

Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United States
por: Mojica, Maria F., et al.
Publicado: (2019)

Violence: The scourge of Indian industry
por: Srivastava, Kalpana, et al.
Publicado: (2018)

Molecular Characterization of Extended-Spectrum β-Lactamase-Producing Multidrug Resistant Escherichia coli From Swine in Northwest China
por: Liu, Xiaoqiang, et al.
Publicado: (2018)

Characteristics and Epidemiology of Extended-Spectrum β-Lactamase-Producing Multidrug-Resistant Klebsiella pneumoniae From Red Kangaroo, China
por: Wang, Xue, et al.
Publicado: (2020)

Quantitative Insights Into β-Lactamase Inhibitor’s Contribution in the Treatment of Carbapenemase-Producing Organisms With β-Lactams
por: Feng, Yanfang, et al.
Publicado: (2021)

Activity of newest generation β-lactam/β-lactamase inhibitor combination therapies against multidrug resistant Pseudomonas aeruginosa
por: Haines, Robbie R., et al.
Publicado: (2022)

698. In vitro Activity of a New Generation Oxopyrazole Antibiotic Against Multidrug-Resistant Gram-Negative Bacilli
por: Goldberg, Joel, et al.
Publicado: (2019)

High Prevalence of Multidrug-Resistant Klebsiella pneumoniae Harboring Several Virulence and β-Lactamase Encoding Genes in a Brazilian Intensive Care Unit
por: Ferreira, Roumayne L., et al.
Publicado: (2019)

The gut microbiome: scourge, sentinel or spectator?
por: Korecka, Agata, et al.
Publicado: (2012)

ARSENIC: In Search of the Roots of a Scourge
por: Potera, Carol
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_45on4h3hqh9g82boktbpjc166d